Cyclophosphamide/GM-CSF priming in autotransplant therapy for CML.
McGlave
P
P
Bone Marrow Transplantation Program, University of Minnesota Academic Health Center, Minneapolis 55455, USA.
Bhatia
R
R
Verfaillie
C
C
D000328:Adult; D016026:Bone Marrow Transplantation / Q000379:methods*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D014182:Transplantation, Autologous
D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide